GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

111 papers

Active filtersClassification:Supporting

Showing 37-48 of total 111 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Health-Related Quality of Life and Cost-Effectiveness of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Monotherapy in Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Systematic Review.

Kumar S; Mudgal SK; Varikasuvu SR; Singh D; Singh H; Mahato S; Sarangi PK; Mondal H

Jan 1, 2026Cureus

2026PubMedSupporting evidence

Autologous Bone Grafting for the Treatment of Osteochondral Lesion of the Talus: A Systematic Review and Meta-Analysis.

Law KHK; Koh JH; Seow D

Jan 1, 2026Journal of the American Podiatric Medical Association

2026PubMedSupporting evidence

Clinical Efficacy of Ureteroscopy Versus Laparoscopic Ureterolithotomy in the Treatment of Large Proximal Ureteral Stones (>1 cm): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Wang E; Tang P; Chen C

Jan 1, 2026Urology journal

2026PubMedSupporting evidence

Non-pharmacological therapy for pediatric adenoid hypertrophy: a systematic review and network meta-analysis.

Guo F; Liu R; Zou Y; Li X; Xie M; Yao Y; Liu Q

Jan 1, 2026Frontiers in pediatrics

2026PubMedSupporting evidence

Beyond Glycated Hemoglobin (HbA1c): A Systematic Review of Metabolic Interventions, Insulin Resistance, and Cognitive Function Across the Obesity-to-Diabetes Continuum.

Nathaniel E; Himon AK; Khalid RD; Ahuja O; Aurangzeb RF; Kanwal S; Gowda V; Nemani P

Jan 1, 2026Cureus

2026PubMedSupporting evidence

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

Danovitch I; Truman K; Brown H; Miller M; Shah S; Totlani J; Kaidbay DN; Tessema KK; Minasyan Z; IsHak WW; Miles S; Pechnick RN

Jan 1, 2026CNS drugs

2026PubMedSupporting evidence

Glucagon-Like Peptide-1 Agonists and the Incidence of Atrial Fibrillation in Obese Patients With Heart Failure With Preserved Ejection Fraction and No Diabetes.

Rassam F; Lopez EK; Sass S; Srikulmontri T; Isaacs E; Malin J; Wattanachayakul P; Afolabi-Brown O

Jan 1, 2026Journal of arrhythmia

2026PubMedSupporting evidence

Heart failure with a preserved ejection fraction: synergy between cardiac and extracardiac mechanisms and effects of novel therapies.

Nassiri S; Handoko ML; van de Bovenkamp AA; van Empel VPM; van Raalte DH; Eringa EC

Jan 1, 2026Heart failure reviews

2026PubMedSupporting evidence

Patient and healthcare professional perceptions of weight reduction in the treatment of knee osteoarthritis: A systematic literature review.

Conaghan PG; Rolland C; Frampton J; Lavoie L; Giblin K; Robinson R; Perez-Nieves M

Jan 1, 2026Osteoarthritis and cartilage open

2026PubMedSupporting evidence

Immunometabolic Regulation of Macrophage Function in Cardio-Hepatic-Renal Comorbidities: Mechanisms and Therapeutic Opportunities.

Bai X; Bai J; Zhou Y

Jan 1, 2026Molecular and cellular endocrinology

2026PubMedSupporting evidence

Epigenetic determinants of GLP-1 responsiveness: Integrating dietary modulation beyond genetics.

Shin HR; Kim TY; Min K; Park UH; Oh SW; Kim JK

Jan 1, 2026Obesity research & clinical practice

2026PubMedSupporting evidence

GLP-1 agonists before endoscopy: separating fact from fiction.

Shah T

Jan 1, 2026Current opinion in gastroenterology